• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Role of DNAM-1 (CD226) in rapid progressive glomerulonephritis

Research Project

Project/Area Number 20890030
Research Category

Grant-in-Aid for Young Scientists (Start-up)

Allocation TypeSingle-year Grants
Research Field Kidney internal medicine
Research InstitutionUniversity of Tsukuba

Principal Investigator

KAI Hirayasu  University of Tsukuba, 大学院・人間総合科学研究科, 講師 (60510138)

Project Period (FY) 2008 – 2009
Project Status Completed (Fiscal Year 2009)
Budget Amount *help
¥3,302,000 (Direct Cost: ¥2,540,000、Indirect Cost: ¥762,000)
Fiscal Year 2009: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2008: ¥1,742,000 (Direct Cost: ¥1,340,000、Indirect Cost: ¥402,000)
Keywords急速進行性糸球体腎炎 / DNAM-1(CD226) / 抗糸球体基底膜抗体型糸球体腎炎 / 半月体形成糸球体腎炎 / DNAM-1遺伝子欠損マウス / anti-GBM型糸球体腎炎 / DNAM-1 / anti-GBM抗体
Research Abstract

DNAM-1 (CD226) is an adhesion molecule expressed on the majority of NK cells, T cells, monocytes and platelets and physically and functionally associates with leukocyte function-associated antigen-1 (LFA-1). The poliovirus receptor (PVR) CD155 and its family member CD112 (PVR-related family-2 (PRR-2), also called as nectin-2) are ligands for human and mouse DNAM-1. We analyzed rapid progressive glomerulonephritis for wild type mouse and DNAM-1 (CD226) gene deficit mouse using antiglomerulus basement membrane antibody. We compared wild type mouse with the DNAM-1 gene deficit mouse, and the degree of the nephritis was showed weakly. The possibility that DNAM-1 related with the onset of the rapid progressive glomerulonephritis was suggested.

Report

(3 results)
  • 2009 Annual Research Report   Final Research Report ( PDF )
  • 2008 Annual Research Report

URL: 

Published: 2008-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi